Skip to main content

Table 1 Baseline characteristics of patients in the two studied groups

From: The role of left prefrontal transcranial magnetic stimulation in episodic migraine prophylaxis

 Active (n = 14)Control (n = 19)
Age37.4 (11.7)32.2 (9.8)
Females13 (92.9%)15
Family history of migraine6 (42.9%)8 (42.1%)
Disease duration (years)8.5 (6)7 (4)
Migraine with aura2 (14.3%)2 (10.5 %)
Beck Depression Inventory
 Normal9 (64.3%)17 (89.5)
 Mild2 (14.3%)2 (10.5%)
 Borderline/moderate3 (21.4%)0
Use of prophylaxis4 (28.6%)6 (31.6%)
 Propranolol33
 Amitryptiline10
 Topiramate01
 Valproate Na01
 Cinnarizine01
Migraine attack frequency8.2(2.4)7.3 (2.9)
Migraine attack durationa15.8 (16.4)19.3 (20.4)
Pain intensity (NPRS)8.6 (1.5)9.1(1.2)
Migraine days9.3(1.9)
Severe migraine daysb7.2 (1.8)8.2 (3.2)
HIT-673.2 (5.7)70.6 (8.1)
Severe HIT-6 (60 or more)13 (92.9%)14 (73.7%)
Number of abortive pills15.9 (11.8)13.8 (9.5)
  1. Mean (SD) or patient numbers (percentage), NPRS Numeric Pain Rating Scale, HIT Headache Impact Test
  2. aHours
  3. bNPRS of 7